Telavancin for the treatment of methicillin-resistant staphylococcus aureus osteomyelitis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2675-2677

  Twilla, Jennifer D ^a,b   Gelfand, Michael S ^a,b   Cleveland, Kerry O ^a,b   Usery, Justin B ^a,b  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Daptomycin; Linezolid; Lipoglycopeptide; Tigecycline; Vancomycin

Indexed keywords

C REACTIVE PROTEIN; CEFEPIME; CEFTRIAXONE; CREATININE; DAPTOMYCIN; LINEZOLID; TELAVANCIN; TIGECYCLINE; VANCOMYCIN;

BACKACHE; BACTERIAL ARTHRITIS; CARBUNCLE; CASE REPORT; CHRONIC OSTEOMYELITIS; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEBRIDEMENT; DISKITIS; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIDURAL ABSCESS; ERYTHROCYTE SEDIMENTATION RATE; FECES INCONTINENCE; FEVER; HIP PAIN; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; LAMINECTOMY; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIMB WEAKNESS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PARAPLEGIA; PHLEGMON; SIDE EFFECT; SPINAL CORD COMPRESSION; STENOSIS; URINE INCONTINENCE; WALKING DIFFICULTY;

ACETAMIDES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINOCYCLINE; OSTEOMYELITIS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 80054695362     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr329     Document Type: Letter

References (8)

1. Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2010; 51 Suppl 2: S183-97.
2. Deresinski S. Counterpoint: vancomycin and Staphylococcus aureus - an antibiotic enters obsolescence. Clin Infect Dis 2007; 44: 1543-8.
3. Landersdorfer CB, Bulitta JB, Kinzig M et al Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet 2009; 48: 89-124.
4. Nannini E, Murray BE, Arias CA. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 2010; 10: 516-21.
5. Kosmidis C, Levine DP. Daptomycin: pharmacology and clinical use. Expert Opin Pharmacother 2010; 11: 615-25.
6. Saravolatz LD, Stein GE, Johnson LB. Telavancin: a novel lipoglycopeptide. Clin Infect Dis 2009; 49: 1908-14.
7. Yin LY, Calhoun JS, Thomas TS et al Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model. J Antimicrob Chemother [2009;] 63: 357-60.
8. Telavancin (Vibativ) Prescribing Information. South San Francisco, CA/ Deerfield, IL: Theravance, Inc./Astellas Pharma US, Inc., September 2009.